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Abstract: In this paper, novel liver-targeting nanoparticles (NPs), lactosyl-norcantharidin   
(Lac-NCTD)-associated N-trimethyl chitosan (TMC) NPs (Lac-NCTD-TMC-NPs), were prepared 
using ionic cross-linkage. The physical properties, particle size, and encapsulation efficiency of 
the nanoparticles were then investigated. The continuous line of heterogeneous human epithelial 
colorectal adenocarcinoma cells (Caco-2) cell monolayer model was used to study the transport 
mechanism of Lac-NCTD, and the effects of factors such as time, temperature, pH level, drug 
concentration, enhancers, and inhibitors. This model was also used to indicate the differences 
among Lac-NCTD, Lac-NCTD-associated chitosan NPs (Lac-NCTD-CS-NPs), and Lac-NCTD-
TMC-NPs in the absorption and transportation of membranes. Drug concentration levels were 
measured using high-performance liquid chromatography. Active transport and paracellular 
transport were suggested to be both the primary and secondary mechanisms for Lac-NCTD 
absorption, respectively. Lac-NCTD uptake and absorption were not controlled by pH levels, but 
were positively correlated to uptake time, and negatively correlated to   temperature. The basolat-
eral to apical apparent permeability coefficients (Papps) were higher than those of the apical to 
basolateral values. The inhibitor of P-glycoprotein and the multidrug resistance-associated protein 
2 significantly enhanced the uptake amount of Lac-NCTD. Compared with Lac-NCTD, Lac-
NCTD-CS-NPs and Lac-NCTD-TMC-NPs significantly enhanced drug   absorption.   Additionally, 
the latter exhibited stronger action. Lac-NCTD-NPs could penetrate the plasma membrane of 
Caco-2 cells and translocate into the cytoplasm and even into the nucleus. Nanoparticles were 
uptaken into Caco-2 cells through the endocytosis pathway.
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Introduction
Lactosyl-norcantharidin (Lac-NCTD) is synthesized by modifying NCTD with a 
lactobiose-bearing galactose group to achieve active targeting. The galactose group can 
combine with the asialoglycoprotein receptor situated on the hepatocyte membrane.1,2 
A previous study by the present researchers demonstrated that, compared with NCTD, 
Lac-NCTD has significantly higher therapy efficiency and lower toxicity.3
Chitosan (CS) is a biocompatible, biodegradable, nontoxic polymer. It has been exten-
sively investigated as a formula carrier in delivery systems for therapeutic molecules.4,5 
However, the application of CS has been hampered largely by its solubility only in acidic 
environments, with pH values below 6.0. On the other hand, N-trimethyl chitosan (TMC), 
a partially quaternized chitosan (CS) derivative, can be soluble in the entire pH range and 
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encompasses all the advantages of CS. It can also form nano-
complexes with anionic compounds such as drugs, proteins, and 
DNA through ionotropic gelation. Hence, TMC has potential 
applications in targeted drug-delivery applications.6
To improve the therapeutic efficacy of Lac-NCTD and 
decrease its side effects, Lac-NCTD-loaded liver-targeting 
chitosan nanoparticles (Lac-NCTD-CS-NPs) were success-
fully developed in previous studies.3 Novel liver-targeting 
nanoparticles Lac-NCTD-associated N-trimethyl chitosan 
nanoparticles (Lac-NCTD-TMC-NPs) were then investigated 
and discussed in the present study.
For most therapeutic agents, the oral route is still the most 
convenient for drug administration. Based on this consider-
ation, the present study investigated the absorption mecha-
nisms of Lac-NCTD, and two nanoparticles. The human 
Caco-2 cell line has been widely used as a potent   in-vitro 
model to predict drug absorption in humans, to explore the 
mechanisms of drug absorption, and to identify substrates 
or inhibitors of transporters.7
The present study aims to use Caco-2 cells to develop a 
theoretical basis for the understanding of the oral absorption 
of Lac-NCTD and its nanoparticles, as well as to further char-
acterize both its uptake and transepithelial transport across 
Caco-2 cells. The present study could provide a theoretical basis 
for the formulation and development of a rational design of new 
agents, as well as for the selection of its administration route.
Methods and materials
Materials
Lac-NCTD and TMC were synthesized in our l  aboratory. 
CS (molecular weight [MW] of 8 kDa to 10 kDa, 
deacetylation degree [DD] 93.1%) was purchased from 
Xingcheng B  iochemical Co, Ltd (Nantong, China). Sodium 
t  ripolyphosphate (TPP) was obtained from Sinopharm Group 
Co, Ltd (Shanghai, China).
Caco-2 cells were obtained from Fu Dan University 
(  Shanghai, China). Cell culture reagents were purchased from 
Gibco (Grand Island, New York, NY). All other reagents 
and solvents were of analytical grade and commercially 
available.
High-performance liquid chromatography (HPLC) was 
carried out using a chromatograph consisting of two pumps 
(LC-10AT VP, Shimadzu, Japan) and a UV-vis detector 
(SPD-M10A VP, Shimadzu, Japan) set at 220 nm. The 
reversed-phase column used was a Hypersil ODS-C18 (5 µm 
in 4.6 × 250 mm, Elite, Dalian, China) set to 25°C. The 
mobile phase was a mixture of acetonitrile and H2O (at a ratio 
of 10:90, adjusted to pH 3.2 by adding phosphoric acid) and 
the flow rate was 0.8 mL/minute.
Preparation of Lac-NCTD-TMC-NPs
Lac-NCTD-TMC-NPs were prepared according to the pro-
cedure first reported by Calvo and colleagues,8 which was 
based on the ionic gel of TMC with TPP anions. Briefly, 
0.15 g TMC was dissolved in 50 mL distilled water contain-
ing 0.03 g Lac-NCTD. Then, 25 mL of the TPP (1.2 mg/mL) 
aqueous solution was drip-fed into the TMC solution under 
magnetic stirring (500 rpm) at 30°C, resulting in crosslink-
age. Finally, the opalescent suspension was filtered through 
a 0.45 µm filter to remove any insoluble aggregate residue, 
and to obtain the Lac-NCTD-TMC-NPs suspension.
Evaluation of Lac-NCTD-TMC-NPs
The particle distribution and zeta potential of Lac-NCTD-
  TMC-NPs’ suspension were measured using a Z  etasizer   
nanoparticle analyzer (model HPP-5001; Malvern I  nstru-
ments, Malvern, UK), which works on the principle of laser 
diffraction analysis. The shape of the Lac-NCTD-TMC-NPs 
particles was determined through transmission electron 
microscopy (TEM) analysis, which was performed using an 
H-600 transmission electron microscope (Hitachi, Tokyo, 
Japan).
The drug entrapment efficiency (EE) and drug-loading 
(DL) amount of Lac-NCTD-TMC-NPs were determined as 
described previously.9 Briefly, the Lac-NCTD-TMC-NPs’ 
suspension was ultracentrifuged (250,000 × g for 30 minutes 
at 10°C) in an Optima MAX Centrifuge (Beckman Instru-
ments, Palo Alto, CA). The supernate was sampled, and the 
Lac-NCTD concentration in the supernate was tested using 
a reversed-phase HPLC method.
Cell culture
Caco-2 from a passage between 30 and 50 were used in the 
experiments. The cells were grown in conditions similar 
to those reported earlier. The cells were maintained in 
  Dulbecco’s modified Eagle’s medium (DMEM) with high 
glucose (4.5 g/L), which was supplemented with 15% fetal 
bovine serum, 1% nonessential amino acids, 1% L-glutamine, 
and 0.5% penicillin/streptomycin. All cell cultures were main-
tained in a humidified incubator at 37°C in an atmosphere 
of 5% CO2 and 95% relative humidity. The culture medium 
was changed every two days, and the cells were passaged at 
a ratio of 1:3, every 3 to 5 days (at 70% to 80% confluence), 
using 0.25% trypsin and 0.02% EDTA at 37°C.
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Uptake studies
Caco-2 cells were plated on 12-well tissue culture plates 
(Corning, Corning, NY) at a density of 1 × 105 cells/cm2. 
The cell monolayers were used on the 15th day for uptake 
experiments.
Hank’s balanced salt solution (HBSS; pH 7.4) was used 
as the incubation medium. The Caco-2 cell   monolayers were 
washed twice with the incubation medium, and then prein-
cubated with 1 mL of the incubation medium for 15 minutes 
at 37°C. The medium was then removed after the preincuba-
tion period and uptake was initiated by   adding 1 mL of the 
preincubated drug solution (Lac-NCTD, Lac-NCTD-CS-NPs, 
or Lac-NCTD-TMC-NPs). At various time points, the cells 
were quickly washed three times with cold HBSS, and then 
scraped off using a cell scraper (Corning). Next, the cells were 
homogenated, vortexed, and ultracentrifuged. The supernate 
was sampled, and the accumulated amount of Lac-NCTD 
was assayed by HPLC. The protein content was measured 
according to Bradford’s method.10
Transport studies
Caco-2 cells were seeded at a density of 1 × 105 cells/cm2 onto 
a permeable polycarbonate insert (1.1 cm2, 1 µm pore size) 
(Millipore, Billerica, MA) in 12-well tissue culture plates 
(Corning). On the 21st day, the cell monolayers were used 
for transepithelial transport experiments. The i  ntegrity of the 
monolayers grown on the permeable membrane was assessed 
using the transepithelial electrical resistance (TEER) of the 
monolayers, through a Millicell-ERS a  pparatus (Millipore) 
and phenol red transport. Caco-2   monolayers could only 
be used in the experiments when TEER values reached 
700  Ω ⋅ cm2 and phenol red permeability was ,0.5% per 
hour.
The culture medium of both sides was removed by aspira-
tion, and the Caco-2 cell monolayers were washed twice with 
the incubation medium. After washing, the   monolayers were 
preincubated for 15 minutes at 37°C with 0.5 and 1.5 mL of 
the incubation medium in the apical and basolateral sides, 
respectively. After the preincubation, the medium was 
removed immediately, and the incubation medium containing 
Lac-NCTD and its nanoparticles (Lac-NCTD-CS-NPs and 
Lac-NCTD-TMC-NPs) were added to either the apical side 
(0.5 mL) or the basolateral side (1.5 mL). The unmodified 
incubation medium was then added to the opposite side 
(basolateral, 1.5 mL; apical, 0.5 mL). Next, 50 µL samples 
were taken from the receiver compartment at intervals of   
5, 15, 30, 45, and 60 minutes, and replaced with a fresh buffer. 
Concentrations in the transepithelial transport samples were 
determined using the HPLC method as described above.
Subcellular localization of NPs
To detect cellular uptake using a laser scanning confocal 
microscope, Lac-NCTD-CS-NPs and Lac-NCTD-TMC-NPs 
were labeled with fluorescein isothiocyanate (FITC). The FITC-
labeled CS and TMC were prepared by the reaction between the 
isothiocyanate group of FITC and the primary amino group of 
CS and TMC, as described by Huang and colleagues.11
The Caco-2 cells were seeded on 6-well dishes at a d  ensity 
of 1 × 105 cells/cm2. FITC-Lac-NCTD-TMC-NPs and FITC-
Lac-NCTD-TMC-NPs were added to the cells and incubated 
for 15, 30, and 60 minutes. The cells were washed three 
times with PBS, fixed with 4% paraformaldehyde, and then 
stained with 10 µg/mL Hochest 33258 (Sigma-Aldrich, 
St Louis, MO). Micrographs were taken on a Nikon laser 
scanning confocal microscope (Nikon Eclipse TE2000-E; 
Nikon, Tokyo, Japan).
Uptake process of NPs
The Caco-2 cells were seeded on 6-well dishes at a density of 
1 × 105 cells/cm2. Lac-NCTD-TMC-NPs were added to the 
cells and incubated for 4 hours. The cells were then washed 
three times with PBS, twice with distilled water, and then 
fixed with 4% paraformaldehyde. Micrographs were taken 
on an atomic force microscope (AFM; MultiMode V; Veeco 
Instruments, Woodbury, NY).
Data and statistical analysis
The Lac-NCTD EE and DL amounts were calculated as 
follows:
  EE
TF
TL
=×
−
−
100%   (1)
 
DL
T
W
=× 100%
 
(2)
where T is the total Lac-NCTD in the colloid, F is the 
free Lac-NCTD in the supernate, and W is the weight of 
  Lac-NCTD-TMC-NPs.
The Papp was calculated according to the equation
 
Papp
dQ dt
AC
=
/
0
  (3)
where dQ/dt is the slope of the cumulative amount   transported 
during the time course of the period studied  , A is the area of 
the inserts, and C0 is the starting concentration.
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Permeability direction ratios (PDR) were calculated 
according to the following equation:
 
PDR
Papp BL AP
Papp AP BL
=
−
−
()
()
  (4)
where AP-BL is the apical to basolateral transport and 
BL  -  AP is the basolateral to apical transport.
All data were reported as mean ± standard deviation 
for at least three independent samples. Data were analyzed 
by one-way ANOVA with the post hoc Tukey’s test applied 
for paired comparisons using SPSS software (version 16.0; 
SPSS, Chicago, IL). The criteria for statistical significance 
were taken as  *P , 0.05, **P , 0.01,  #P , 0.05, and 
##P , 0.01 (Figures 5–7; Tables 1,3).
Results
Preparation and evaluation of  
Lac-NCTD-TMC-NPs
Lac-NCTD-TMC-NPs were prepared through an ionic cross-
linking process and evaluated in terms of the NPs EE, DL, 
particle size, and polydispersity index (PDI). The particle size 
of Lac-NCTD-TMC-NPs was around 120 nm (PDI , 0.3) 
(Figure 1). The zeta potential of Lac-NCTD-CS-NPs was 
28.08 ± 3.95 mV , whereas that of Lac-NCTD-TMC-NPs was 
37.37 ± 3.62 mV , mainly because of the high degree of TMC 
quaternization (65%).
The  EE  and  DL  of  Lac-NCTD-TMC-NPs  were 
69.29% ± 0.76% and 9.1% ± 0.07%, respectively. A TEM 
image of the Lac-NCTD-TMC-NPs is shown in Figure 2. 
Under TEM, most of the NPs appeared to be uniform and 
round, with the majority of particles separated from one 
another.
Linearity, precision, and accuracy  
of Lac-NCTD determination
Under the conditions described above, the Lac-NCTD 
retention was at 5.1 minutes. The active component test 
was uncontaminated, and also had high specificity. In a 
0.1 µg/mL to 52 µg/mL concentration range, Lac-NCTD 
in PBS/blank cells homogenate showed a good linear 
  relationship. Recovery was 98.99% to 102.46% within the 
linear range, and relative standard deviation was below 5%, 
both of which fitted the requirements for analyzing the   
biological specimen.
Uptake of Lac-NCTD into Caco-
2 monolayers
Effect of time on the uptake of Lac-NCTD
The uptake of Lac-NCTD (250 µg/mL) into Caco-2 monolay-
ers was shown to be linear in relation to time, from 0 minutes to 
30 minutes at 37°C (Figure 3). To ensure the optimal absorp-
tion rate, the uptake time of the drug should be determined 
1.0
0
2.0
4.0
6.0
8.0
10.0
10.01 00.0
Diameter (nm)
Size distribution by intensity
Record 37:37
I
n
t
e
n
s
i
t
y
 
(
%
)
1000.0 10000.0
Figure 1 Particle size distribution analysis using a Zetasizer Nano particle analyzer.
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Figure 2 TEM micrograph of Lac-NCTD-TMC-NPs.
Abbreviations: TEM, transmission electron microscopy; Lac-NCTD-TMC-NPs, 
lactosyl-norcantharitin (Lac-NCTD)-associated N-Trimethyl chitosan nanoparticles.
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Figure 3 Time course of Lac-NCTD uptake in Caco-2 cell monolayers.
Note:  Error  bars  represent  standard  error  of  the  mean  value  for  three 
determinations.
Abbreviations:  Lac-NCTD,  lactosyl-norcantharitin;  Caco-2,  continuous  line  of 
heterogeneous human epithelial colorectal adenocarcinoma cells.
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within its linear absorption range. Considering the nature 
of the drug, cell characteristics, and operational feasibility, 
15 minutes was set as the uptake time for the subsequent 
experiments.
Effect of concentration on the uptake of Lac-NCTD
Concentration dependence or saturation was observed for 
the uptake of Lac-NCTD in the concentration range of 
100 µg/mL to 400 µg/mL (Figure 4).
Effect of pH and temperature
The uptake amount of Lac-NCTD (250 µg/mL) into 
Caco-2 monolayers in pH 6.0 and 7.4 were (0.82 ± 0.23) 
and (0.80 ± 0.15) mg/g protein, respectively. There were no 
significant differences between the uptake amounts in the two 
pH values (P . 0.05). Hence, the subsequent experiments 
were performed using the medium at pH 7.4.
The uptake amount of Lac-NCTD (250 µg/mL) into 
Caco-2 monolayers in 4°C and 37°C were (1.35 ± 0.13) and 
(0.80 ± 0.15) mg/g protein, respectively. The uptake of Lac-
NCTD across Caco-2 cell monolayers showed temperature 
dependence, and was enhanced at low temperatures.
Effect of protein inhibitor
The saturation possibility of the P-glycoprotein (P-gp) 
and the multidrug resistance-associated protein 2 (MRP2) 
function was investigated in the present study. Hence, the 
uptake of Lac-NCTD across Caco-2 in solutions with added 
P-gp or MRP2 inhibitors 20 µmol/L cyclosporine (CyA) or 
50 µmol/L MK-571 was investigated. Results are shown 
in Figure 5, which indicate that CyA and MK-571 can 
  facilitate the uptake procedure. However, the latter had an 
even stronger action.
Uptake of Lac-NCTD-NPs into Caco-2 monolayers
The uptake of Lac-NCTD-NPs (Lac-NCTD-CS-NPs,   
Lac-NCTD-TMC-NPs) and Lac-NCTD solution at a dose of 
250 µg/mL at 37°C was investigated. The results are shown 
in Table 1. Among the three formulations, the order of uptake 
amount was Lac-NCTD-TMC-NPs . Lac-NCTD-CS-NPs .   
Lac-NCTD solution.
Transport of Lac-NCTD across Caco-
2 monolayers
Effect of concentration on the transport  
of Lac-NCTD
The influence of concentration on the transport of Lac-NCTD 
across the Caco-2 cell monolayers was measured (Table 2). 
The bidirectional transport data for Lac-NCTD showed that 
the secretory Papp (BL-AP) of Lac-NCTD was higher than 
its absorptive Papp (AP-BL) at every concentration point, 
indicating the existence of efflux proteins.12–13
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Figure 4 Effect of Lac-NCTD concentration on Caco-2 cells uptake.
Note:  Error  bars  represent  standard  error  of  the  mean  value  for  three 
determinations.
Abbreviations:  Lac-NCTD,  lactosyl-norcantharitin;  Caco-2,  continuous  line  of 
heterogeneous human epithelial colorectal adenocarcinoma cells.
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Figure 5 Effect of CyA and MK-571 on Caco-2 cells uptake.
Notes: **P , 0.01 versus control group; ##P , 0.01 versus control group. Error 
bars represent standard error of the mean value for three determinations.
Abbreviations: CyA, cyclosporine; MK-571, Sigma-MK-571 sodium salt hydrate;   
Caco-2,  continuous  line  of  heterogeneous  human  epithelial  colorectal  adeno-
carcinoma cells.
Table 1 Uptake of Lac-NCTD on Caco-2 cells with different 
preparations (n = 3)
Preparations
Lac-NCTD Lac-NCTD- 
CS-NPs
Lac-NCTD- 
TMC-NPs
Uptake (mg/g protein) 0.80 ± 0.15 1.54 ± 0.32** 1.73 ± 0.17**,#
Notes: **P , 0.01 versus Lac-NCTD; #P , 0.05 versus Lac-NCTD-CS-NPs.
Abbreviations:  Lac-NCTD,  lactosyl-norcantharitin;  Caco-2,  continuous  line  of 
heterogeneous human epithelial colorectal adenocarcinoma cells.
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Effects of protein inhibitor on bi-directional 
transport of Lac-NCTD
The efflux transport of Lac-NCTD (250 µg/mL) was inves-
tigated in the presence of CyA (20 µmol/L) and MK-571 
(50 µmol/L). The results are shown in Figure 6. When CyA 
was added, the Papp of the apical to basolateral direction 
increased, and the Papp of the basolateral to apical direction 
decreased. When MK-571 was added, the Papp of the apical 
to basolateral direction significantly increased, and the Papp 
of the basolateral to apical direction lightly decreased.
Effect of endocytosis inhibitors and bypass transport 
enhancers
The transport of Lac-NCTD (250 µg/mL) across Caco-2 in 
solutions with added endocytosis inhibitor oxophenylarsine 
25 mmol/L or bypass transport enhancer sodium deoxy-
cholate (SDCh) 100 mmol/L was also investigated. As shown 
in Figure 7, the Papp significantly increased after SDCh 
(P , 0.05) was added. However, no statistical difference 
in Papp existed between the oxophenylarsine group and the 
control group.
Transport of Lac-NCTD-NPs across 
Caco-2 mono1ayers
The bidirectional transport of Lac-NCTD-NPs (Lac-NCTD-
CS-NPs, Lac-NCTD-TMC-NPs) and Lac-NCTD solution at 
a dose of 250 µg/mL at 37°C was also investigated. Results 
are shown in Table 3.
Subcellular localization of NPs
The uptake of Lac-NCTD-NPs (Lac-NCTD-CS-NPs,   
Lac-NCTD-TMC-NPs) by human Caco-2 cells was evalu-
ated by laser scanning confocal microscopy (Figure 8). After 
incubating 250 µg/mL of FITC-labeled Lac-NCTD-NPs 
with Caco-2 cells for 15, 30, and 60 minutes, the cells were 
fixed and the nuclei were stained with Hochest 33258. The 
fluorescence intensity profiles for both Lac-NCTD-CS-NPs 
and Lac-NCTD-TMC-NPs were roughly comparable. After 
15 minutes of incubation, the Lac-NCTD-NPs mostly gath-
ered in the surface of the cell membrane, and a small part 
gathered into the cytoplasm (Figure 8, green fluorescence). 
As the incubation time was extended, more NPs gathered in 
the cytoplasm, and even inside the nucleus.
Table 2 Papp of Lac-NCTD at different concentrations in Caco-2 
cells (n = 3)
Lac-NCTD
(μg/mL)
Papp (×10-6) Ratio 
PB-A/PA-B AP-BL BL-AP
100 3.29 ± 0.34 6.29 ± 0.43 1.91
250 3.67 ± 0.17 6.76 ± 0.28 1.845
400 3.34 ± 0.22 4.58 ± 0.15 1.37
Abbreviations: Lac-NCTD, lactosyl-norcantharitin-associated; Caco-2, continuous 
line of heterogeneous human epithelial colorectal adenocarcinoma cells.
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Figure 6 Effect of CyA, MK-571 on the transport of Lac-NCTD.
Notes: *P , 0.05 versus control group; **P , 0.01 versus control group; ##P , 0.01 
versus control group. Error bars represent standard error of the mean value for 
three determinations.
Abbreviations: CyA, cyclosporine; MK-571, Sigma-MK-571 sodium salt hydrate; 
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Figure 7 Effect of oxophenylarsine and SDCh on the transport of Lac-NCTD.
Notes: #P , 0.05 versus control group. Error bars represent standard error of the 
mean value for three determinations.
Abbreviations: SDCh, sodium deoxycholate; Lac-NCTD, lactosyl-norcantharitin.
Table  3  Papp  of  Lac-NCTD  on  Caco-2  cells  with  different 
preparations (n = 3)
Preparations
(250 μg/mL)
Papp (×10-6) Ratio
PB-A/PA-B AP-BL BL-AP
Lac-NCTD solution 3.67 ± 0.68 6.76 ± 1.12 1.85
Lac-NCTD-CS-NPs 5.38 ± 0.23** 6.01 ± 0.45* 1.11**
Lac-NCTD-TMC-NPs 5.73 ± 0.44**,# 6.12 ± 0.67* 1.07**
Notes: *P , 0.05 versus Lac-NCTD; **P , 0.01 versus Lac-NCTD;  #P , 0.05 
versus Lac-NCTD-CS-NPs.
Abbreviations:  Lac-NCTD,  lactosyl-norcantharitin;  Caco-2,  continuous  line  of 
heterogeneous human epithelial colorectal adenocarcinoma cells.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1926
Guan et alInternational Journal of Nanomedicine 2012:7
A-1A -2 A-3
B-1B -2 B-3
C-1C -2 C-3
D-1D -2 D-3
E-1E -2 E-3
F-1F -2 F-3
Figure 8 Laser scanning confocal microscopy images showing uptake and subcellular 
localization of FITC-labeled Lac-NCTD-CS-NPs and FITC-labeled Lac-NCTD-TMC-
NPs. Panel 1. Green fluorescence shows the location of FITC-labeled Lac-NCTD-
CS-NPs or FITC-labeled Lac-NCTD-TMC-NPs. Panel 2. Blue fluorescence shows 
nuclear staining with Hoechst33258. Panel 3. Overlaid image of Panel 1 and Panel 2. 
(A, C, E): Lac-NCTD-CS-NPs groups. (B, D, F): Lac-NCTD-TMC-NPs groups. 
(A and B): 15 min. (C and D): 30 min. (E and F): 60 min.
Abbreviations: FITC-labeled, fluorescein isothiocyanate-labeled; Lac-NCTD-CS-NPs, 
lactosyl-norcantharitin  (Lac-NCTD)-associated  N-Trimethyl  chitosan  nanoparticles; 
Lac-NCTD-TMC-NPs,  lactosyl-norcantharitin  (Lac-NCTD)-associated  N-Trimethyl 
chitosan nanoparticles.
Uptake process of NPs
The uptake of Lac-NCTD-TMC-NPs by human Caco-2 cells 
was observed using atomic force microscopy (Figure 9).
Figure 9A shows the surface of Caco-2 cells without any 
treatment. Figure 9B shows the cells’ surface morphology 
when treated with nanoparticles for 4 hours. The surface is 
relatively flat in Figure 9A, whereas multiple depressions are 
present in Figure 9B. These changes indicated the occurrence 
of endocytosis.
A statistical analysis of the height of the protruding 
  particles on the cell surface (Figure 10) then followed. 
Figure 10A shows the Caco-2 cell surface without any 
treatment. The height of the protruding particles was mostly 
located from 100 nm to 150 nm. Figure 10B shows the cell 
surface morphology when treated with nanoparticles for 
4 hours. The height of protruding particles mostly gathered 
at 280 nm. The height difference between 10A and B was 
consistent with the particle size of the nanoparticles.
Discussion
In the present study, a novel liver-targeting drug-delivery system   
(Lac-NCTD-TMC-NPs) with stable EE and high DL efficacy 
was prepared. The particle size of Lac-NCTD-TMC-NPs was 
120.6 ± 1.7 nm. The majority of fenestrated liver sinusoids 
were, usually, smaller than 200 nm in diameter.14 Additionally, 
several abnormalities existed between tumor blood vessels 
and physiologically normal vessels, including a relatively 
high proportion of proliferation in vivo, increased tortuosity, 
aberrant basement membrane formation, and enhanced per-
meability.15–17 Thus, the prepared Lac-NCTD-TMC-NPs, with 
a mean particle size of around 120 nm, can pass through the 
fenestrated sinusoids and accumulate in the tumor sites of the 
liver. The small particle size reduced the adverse reaction of 
Lac-NCTD-TMC-NPs on normal hepatic cells, by reducing 
the passive targeting in the liver. The TEM image suggested 
that these nanoparticles were probably ionically stabilized 
against particle agglomeration, due to the positive charges 
on their surface.
The intestinal transport mechanism of Lac-NCTD and 
its NPs was also investigated in the present study using 
Caco-2 cells. In recent years, the Caco-2 cell model has 
become a popular model of the intestinal mucosa18 due to the 
fact that these cells have a colonic origin, and express trans-
porters which are normally found in the intestinal mucosa. 
Among these transporters, some promote drug absorption.19 
However, others (P-gp, MRP2, and MRP1) are known to 
restrict drug absorption in the intestinal mucosa.20
In the uptake study, concentration dependence or 
saturation was observed for the uptake of Lac-NCTD in 
the concentration range of 100 µg/mL to 400 µg/mL. This 
finding suggests that active transport occurred during the 
uptake process. The effects of pH level and temperature on 
the uptake of Lac-NCTD in Caco-2 monolayers were also 
studied. The uptake amount of Lac-NCTD in Caco-2 cells 
was observed to be dependent on temperature, but not on 
pH values. Generally, in low temperatures, the generation 
of adenosine triphosphate (ATP) is blocked, and so active 
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transport is inhibited; therefore the uptake amount of   
Lac-NCTD in Caco-2 cells should be reduced. However, the 
experimental result was contrary to this finding. According 
to the literature,21,22 Caco-2 cells highly express drug efflux 
transporters, which are energy-dependent drug efflux pumps. 
The uptake amount was enhanced at a low temperature, sug-
gesting the presence of efflux proteins.22–24
Previous studies have demonstrated that a class of pro-
teins is related to drug uptake and intracellular transport.25,26 
In addition to P-gp, MRP2 also plays a targeted transport 
pump role, affecting the intestinal absorption of compounds. 
These two types of protein are both expressed in Caco-2 cells; 
thus, specific inhibitors were applied in the present study to 
observe the interaction between Lac-NCTD and inhibitors. 
Results showed that P-gp and MRP2 each play an important 
role in the uptake and transport process of Lac-NCTD. When 
either CyA (20 µmol/L) or MK-571 (50 µmol/L) was added 
to the apical side of Caco-2 cell monolayers, the Papp of 
the apical to basolateral direction significantly increased by 
1.41 and 2.29 times, respectively.
Both P-gp and MRP2 efflux pumps are located predomi-
nantly in the apical membranes of the epithelia (eg, small 
intestine, colon), making the secretion rate faster than the 
absorption rate.27 Efflux proteins show a strong efflux effect 
in low drug concentrations, and become saturated in high 
drug concentrations. When the Lac-NCTD concentration 
increased from 100 µg/mL to 400 µg/mL, the ratios of 
Papp BL-AP to Papp AP-BL decreased from 1.91 to 1.37, 
respectively. Between the two types of efflux proteins, 
MRP2 showed a stronger action. This conclusion needs to 
be verified further, using a MDCK-MRP2 cell model.
Figure 7 shows the effects of oxophenylarsine and SDCh, 
which were added to the apical side of Caco-2 cell monolay-
ers on the transport of Lac-NCTD. The paracellular transport 
enhancer SDCh promoted the absorption of Lac-NCTD, while 
the endocytosis inhibitor oxophenylarsine had no effect. This 
indicates that only a small proportion of Lac-NCTD was trans-
ported by the paracellular mode, which speculation is consistent 
with the physical and chemical properties of Lac-NCTD. Water-
soluble small molecule compounds and paracellular transport 
are common modes of transport for these types of drugs.
The uptake and transport studies of NPs have shown that 
in the same concentrations, absorption of Lac-NCTD-CS-
NPs and Lac-NCTD-TMC-NPs was greater than that of the 
Lac-NCTD solution. Additionally, Lac-NCTD-TMC-NPs 
have a stronger action; thus, NPs can improve the cell uptake 
and transportation of drugs. Adsorptive endocytosis has been 
suggested to exist as a nonspecific interaction of the cell 
180.4 nm
−28.9 nm
10.0 µm
378.9 nm
−8.2 nm
10.0 µm
378.9 nm
−8.2 nm
10.0 nm
10.0 µm
10.0 µm
180.4 nm
−28.9 nm
10.0 µm
7.5
7.5
5.0
5.0
2.5
7.5
10
7.5
5.0
5.0
7.5
5.0
2.5
2.5
2.5
2.5
2.5
2.5
2.5
5.0
5.0
5.0
5.0
7.5
7.5
7.5
7.5
10.0 µm 10.0 µm
2.5
2.5
5.0
7.5
10
10.0 µm 
0.0 µm 
2.5
A
B
Figure 9 Atomic force microscope micrograph of Caco-2 cells. A: Caco-2; B: Caco-2 after treatment with Lac-NCTD-TMC-NPs. (10 µm × 10 µm).
Abbreviations: Caco-2, continuous line of heterogeneous human epithelial colorectal adenocarcinoma cells; Lac-NCTD-TMC-NPs, lactosyl-norcantharitin (Lac-NCTD)-
associated N-Trimethyl chitosan nanoparticles.
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membrane with the NPs. Meschini and colleagues reported 
that higher intracellular content of a drug via endocytosis of a 
carrier can remarkably increase its therapeutic effect against 
the target cells.16 On the other hand, CS and TMC can improve 
uptake. The mechanism is that CS and TMC can open tight 
junctions.17 TMC’s high degree of   quaternization (65%) 
enables high absorption-enhancing properties.   Moreover, 
TMC-containing formulations reportedly exceed the potency 
of CS in mucoadhesion.28 In particular, as shown in Table 3, 
the Papp BL-AP of NPs was greater than the Papp AP-BL, 
and the ratios of Papp BL-AP to Papp AP-BL were largely 
reduced compared with the Lac-NCTD solution.
These results suggested that after being encapsulated in CS 
or TMC, a small portion of Lac-NCTD was directly transported 
into the cells in nanoparticle form, effectively bypassing the 
need for efflux proteins. Therefore, for multidrug-resistant 
cells with a decreased drug uptake, CS-NPs or TMC-NPs can 
act as a transmembrane delivery vehicle, to help transport the 
drug molecules into the cells. Thus, CS-NPs or TMC-NPs can 
decrease drug efflux as well as increase cell internalization and 
intracellular accumulation of the drugs.29
Efficient cellular internalization of nanoparticles is 
necessary, for both intracellular drug delivery, and efficient 
therapy. The results in Figure 8 proved that Lac-NCTD-
NPs can penetrate the plasma membrane of Caco-2 cells, 
and, from there, translocate into the cytoplasm, and even 
into the nucleus. CS was regarded as a versatile polymer.30 
  Nanoparticles made of polymer materials may pass through 
the nuclear pore, and then enter the nucleus during the 
cell division process.31 Additionally, the positive charge of   
CS-NPs and TMC-NPs enables an electrostatic interaction 
with the phosphate groups of nucleic acids.32 Isolated spots 
of green fluorescence showed higher fluorescence intensity 
in some cells, demonstrating the cluster of the nanoparticles. 
The figures obtained from atomic force microscopy (Figure 9) 
indicate that nanoparticle uptake into cells occurred through 
an endocytosis pathway. The combination of the nanoparticles 
and the cells is relatively secure.
Conclusion
Active transport and paracellular transport are suggested as 
both main and secondary mechanisms for the absorption of 
Lac-NCTD, respectively. Lac-NCTD uptake and absorption 
are not controlled by pH levels; however, they are positively 
correlated to uptake time, and negatively correlated to 
  temperature. The Papp of the basolateral to apical direction 
is higher than that of the apical to basolateral direction. The 
P-gp and MRP2 inhibitor significantly enhances the uptake 
amount of Lac-NCTD. Compared with Lac-NCTD, Lac-
NCTD-CS-NPs and Lac-NCTD-TMC-NPs also significantly 
enhance drug absorption. Lac-NCTD-NPs can penetrate the 
plasma membrane of Caco-2 cells and translocate into the 
cytoplasm, and even into the nucleus.
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